Rama Padmanabhan focuses her practice on all types of public and private merger and acquisition transactions, including options to buy, cross border transactions, joint ventures and other complex transactions. In addition to her M&A practice, Rama has extensive experience in public company representation, emerging company representation, venture capital financings and private and public securities offerings. Rama is a market leader in SPAC M&A transactions, representing both target companies and investors in the de-SPAC process in transactions ranging in value up to $5 billion. She has experience representing technology, life sciences and other companies, including software, semi-conductor, biotechnology, medical device, aviation, restaurant, gaming and apparel companies. She was named Dealmaker of the Year in Healthcare, Pharma & Biotech at the Deal’s 2020 Middle Market Awards.

Download full bio 

Experience

  • Japan’s Paidy Agrees to Sell to PayPal for $2.7 Billion 

  • Kredivo Agrees to SPAC Merger With VPC Impact Acquisition Holdings II 

  • Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company 

  • Horizon Therapeutics to Acquire Viela Bio 

  • Genesis MedTech Acquires Drug Device Asset From TriReme Medical 

  • View all

Education

  • Harvard Law School

  • John F. Kennedy School of Government, Harvard University

  • Mount Holyoke College
    AB, Mathematics and Economics


Admissions & Credentials

California

Memberships

  • American Bar Association

  • South Asian Bar Association of San Diego, past Director and Vice President

  • Harvard Kennedy School of Community of San Diego, Board of Supervisors